methyl methanesulfonate has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karantzelis, N; Kotsantis, P; Lygerou, Z; Nishitani, H; Petropoulou, C; Roukos, V; Stathopoulou, A; Taraviras, S | 1 |
| Chou, WC; Hsiung, CN; Hu, LY; Shen, CY | 1 |
2 other study(ies) available for methyl methanesulfonate and tamoxifen
| Article | Year |
|---|---|
Cdt1 is differentially targeted for degradation by anticancer chemotherapeutic drugs.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; HeLa Cells; Hep G2 Cells; Humans; Methyl Methanesulfonate; Neoplasms; Proteolysis; Tamoxifen; Ultraviolet Rays | 2012 |
Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
Topics: Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Line; Checkpoint Kinase 2; DNA Damage; DNA Glycosylases; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Methyl Methanesulfonate; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Radiation, Ionizing; Reference Values; Tamoxifen | 2015 |